Dave Daly

Dave brings more than 30 years of cancer diagnostics and executive leadership experience to his role as Chief Executive Officer at Exai. Dave’s most recent roles were Chief Executive Officer and Board Member at Cellworks and President and Chief Operating Officer at Singular Genomics. Previously, Dave served as Chief Executive Officer at Thrive Earlier Detection, a liquid biopsy company focused on multi-cancer early detection that was acquired by Exact Sciences Corporation. During his extensive career in diagnostics, Dave has also served in key leadership roles at Illumina where he was Senior Vice President and General Manager of Commercial Operations for the Americas Region, Foundation Medicine where he was Chief Commercial Officer, Life Technologies where he led the oncology business unit, and Clarient where he served as Chief Commercial Officer. Dave holds a BA in Economics from the University of California, Irvine and an MA in Economics from the University of California, Santa Barbara.